| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.43B | +23.5% |
| Cost of Revenue | $266.5M | +19.5% |
| Gross Profit | $1.16B | +24.4% |
| R&D Expense | $304.7M | +39.6% |
| SG&A Expense | $174.4M | +16.3% |
| Operating Income | $128.4M | +38.3% |
| Interest Expense | $1.4M | -83.7% |
| Pre-tax Income | $154.9M | +72.2% |
| Income Tax | $283K |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $779.0M | +40.3% |
| Short-term Investments | $57.9M | — |
| Accounts Receivable | $602.7M | +36.2% |
| Current Assets | $1.61B | +43.6% |
| Total Assets | $3.41B | +23.3% |
| Current Liabilities | $1.26B | +21.4% |
| Total Liabilities | $1.39B | +20.1% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $378.1M | +6.5% |
| Capital Expenditures | $26.5M | +22.8% |
| Investing Cash Flow | -$193.0M | -796.2% |
| Financing Cash Flow | $50.7M | +121.8% |
| Free Cash Flow | $351.6M | +5.5% |
| +101.6% |
| Net Income | $154.6M | +43.2% |
| EPS (Basic) | $0.53 | +39.5% |
| EPS (Diluted) | $0.52 | +40.5% |
| Stockholders' Equity |
| $2.02B |
| +25.6% |